Cathay Industrial Biotech (CBIO) Files $200M IPO
Tweet Send to a Friend
Cathay Industrial Biotech Ltd. (Nasdaq: CBIO) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of it's American Depositary Shares, or ADSs. The proposed maximum offering price is $200 million. Cathay filed to list on the New York Stock Exchange under the ticker "CBIO."
The offering is being made through Morgan Stanley, Deutsche Bank, and Jefferies.
Cathay Industrial is a global industrial biotechnology company as measured by production capacity in key biochemical products and a pioneer in the commercialization of bioprocess technologies
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The offering is being made through Morgan Stanley, Deutsche Bank, and Jefferies.
Cathay Industrial is a global industrial biotechnology company as measured by production capacity in key biochemical products and a pioneer in the commercialization of bioprocess technologies
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Friday's Hot IPOs Get Even Hotter (MKTO) (DATA)
- William Lyon Homes (WLH) IPO Opens 8% Higher
- Tableau Software (DATA) IPO Surges Higher
Create E-mail Alert Related Categories
IPOsRelated Entities
Deutsche Bank, Morgan Stanley, Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
